Freedman, Ben
Schnabel, Renate B. http://orcid.org/0000-0001-7170-9509
Article History
First Online: 14 November 2022
Competing interests
: B.F. has received speaker fees and travel support for speaking at sessions or official satellites of large international or continental society meetings from Bayer, Bristol-Myers Squibb–Pfizer Alliance, Daiichi Sankyo and Omron; and investigator-initiated research grants to the institution from Bristol-Myers Squibb–Pfizer Alliance. R.B.S. and B.F. have received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme under the grant agreement no. 648131, the European Union’s Horizon 2020 research and innovation programme under the grant agreement no. 847770 (AFFECT-EU). R.B.S. has received funding from the German Center for Cardiovascular Research (DZHK e.V.) (81Z1710103 and 81Z0710114), the German Ministry of Research and Education (BMBF 01ZX1408A), ERACoSysMed3 (031L0239) and Wolfgang Seefried project funding from the German Heart Foundation.